IR contact detailsRoman Akbar-HaaseDirector Investor Relations and Business Developmente: ir@moonlaketx.com Upcoming events Mar 27 - Mar 31 2026 AAD (American Academy of Dermatology) Annual Meeting, Denver, CO Apr 13 - Apr 16 2026 25th Annual Needham Virtual Healthcare Conference, Virtual Apr 15 - Apr 16 2026 Van Lanschot Kempen Life Sciences Conference, Amsterdam, Netherlands View All Events View All Events + Corporate presentations MoonLake Investor Day (Feb 2026) Clinical Data Update (Nov 2025) View All Presentations View All Presentations + Latest press releases Feb 22 2026 MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results Feb 02 2026 MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day Jan 08 2026 MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day View All News View All Press Releases +
Feb 22 2026 MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Feb 02 2026 MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
Jan 08 2026 MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day